StockNews.com began coverage on shares of Inuvo (NYSE:INUV – Get Free Report) in a research report issued on Saturday. The brokerage set a “hold” rating on the stock.
Separately, Maxim Group raised shares of Inuvo to a “strong-buy” rating in a research note on Friday, November 8th.
Get Our Latest Stock Analysis on Inuvo
Inuvo Trading Up 0.3 %
Institutional Trading of Inuvo
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in INUV. Geode Capital Management LLC raised its position in shares of Inuvo by 7.4% during the 3rd quarter. Geode Capital Management LLC now owns 1,069,390 shares of the company’s stock valued at $264,000 after acquiring an additional 73,682 shares during the last quarter. Bard Associates Inc. grew its stake in shares of Inuvo by 7.1% during the third quarter. Bard Associates Inc. now owns 4,234,177 shares of the company’s stock worth $1,044,000 after purchasing an additional 279,100 shares during the period. Finally, Vanguard Group Inc. increased its holdings in Inuvo by 0.8% in the first quarter. Vanguard Group Inc. now owns 5,495,657 shares of the company’s stock valued at $1,874,000 after purchasing an additional 46,290 shares during the last quarter. 29.36% of the stock is currently owned by institutional investors and hedge funds.
About Inuvo
Inuvo, Inc engages in the advertising technology and services business primarily in the United States. It sells information technology solutions to brands, agencies, and large consolidators of advertising demand (platforms). Its platforms optimize the purchase and placement of advertising in real time.
Featured Stories
- Five stocks we like better than Inuvo
- Most active stocks: Dollar volume vs share volume
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Differences Between Momentum Investing and Long Term Investing
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Top Stocks Investing in 5G Technology
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Inuvo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inuvo and related companies with MarketBeat.com's FREE daily email newsletter.